Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis

Fungisome® (F), a liposomal amphotericin B (AmB) product, is marketed in India as a safe and effective therapeutic for the parasitic infection visceral leishmaniasis. Its potential in the treatment of cutaneous leishmaniasis (CL), a disfiguring form of the disease affecting the skin, is currently un...

Full description

Bibliographic Details

Published in:	International Journal for Parasitology: Drugs and Drug Resistance
Main Authors:	Gert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley, Andy Harris, Mo Alavijeh, Rita Silva-Pedrosa, Sandra Antunes, Isabel Mauricio, Sudaxshina Murdan, Simon L. Croft
Format:	Article
Language:	English
Published:	Elsevier 2018-08-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211320718300101